Inventor
CONNOLLY PETER J
US66 patents
⚠️ This page may combine multiple inventors who share the name “CONNOLLY PETER J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
28 patentsUS7541367B2Jun 2, 2009
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
JANSSEN PHARMACEUTICA NV104 citations97
US8759333B2Jun 24, 2014
Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV45 citations94
US8685990B2Apr 1, 2014
Pyrimidine compounds as delta opioid receptor modulators
JANSSEN PHARMACEUTICA NV19 citations92
US8748417B2Jun 10, 2014
Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV9 citations84
US7855205B2Dec 21, 2010
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
JANSSEN PHARMACEUTICA NV9 citations83
US7081463B2Jul 25, 2006
Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders
JANSSEN PHARMACEUTICA NV11 citations82
US7579356B2Aug 25, 2009
Thia-tetraazaacenaphthylene kinase inhibitors
JANSSEN PHARMACEUTICA NV9 citations80
US7655670B2Feb 2, 2010
3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators
JANSSEN PHARMACEUTICA NV8 citations78
US8013153B2Sep 6, 2011
Substituted pyrimidine kinase inhibitors
JANSSEN PHARMACEUTICA NV14 citations76
US8722658B2May 13, 2014
Azetidinyl diamides as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV2 citations74
US8962607B2Feb 24, 2015
Azetidinyl diamides as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV2 citations72
US8697683B2Apr 15, 2014
Azetidinyl diamides as monoacylglycerol lipase inhibitors
JANSSEN PHARMACEUTICA NV2 citations72
US10888550B2Jan 12, 2021
Pyrazole derivatives as MALT1 inhibitors
JANSSEN PHARMACEUTICA NV3 citations71
US7582649B2Sep 1, 2009
Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
JANSSEN PHARMACEUTICA NV7 citations71
US10077261B2Sep 18, 2018
Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer
JANSSEN PHARMACEUTICA NV7 citations70
US10954214B2Mar 23, 2021
Pyrazole derivatives as MALT1 inhibitors
JANSSEN PHARMACEUTICA NV5 citations69
US10501469B2Dec 10, 2019
Substituted thiohydantoin derivatives as androgen receptor antagonists
JANSSEN PHARMACEUTICA NV1 citations69
US7888380B2Feb 15, 2011
1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives
JANSSEN PHARMACEUTICA NV2 citations61
US11040031B2Jun 22, 2021
Pyrazole derivatives as MALT1 inhibitors
JANSSEN PHARMACEUTICA NV2 citations60
US12077521B2Sep 3, 2024
Pyrazole derivatives as MALT1 inhibitors
JANSSEN PHARMACEUTICA NV0 citations59
US10981926B2Apr 20, 2021
Substituted thiohydantoin derivatives as androgen receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations58
US7605154B2Oct 20, 2009
Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors
JANSSEN PHARMACEUTICA NV2 citations58
US10413545B2Sep 17, 2019
Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer
JANSSEN PHARMACEUTICA NV0 citations52
US9718813B2Aug 1, 2017
Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer
JANSSEN PHARMACEUTICA NV0 citations52
US9562035B2Feb 7, 2017
Benzamide derivative useful as FASN inhibitors for the treatment of cancer
JANSSEN PHARMACEUTICA NV1 citations52
US8759533B2Jun 24, 2014
Di-azetidinyl diamide as monoacylglcerol lipase inhibitors
JANSSEN PHARMACEUTICA NV1 citations52
US7635703B2Dec 22, 2009
Imidazole substituted pyrazole kinase inhibitors
JANSSEN PHARMACEUTICA NV0 citations52
US7638518B2Dec 29, 2009
Substituted pyrazole kinase inhibitors
JANSSEN PHARMACEUTICA NV0 citations51
ORTHO MCNEIL PHARM INC
5 patentsUS6750369B2Jun 15, 2004
Substituted amino acids as erythropoietin mimetics
ORTHO MCNEIL PHARM INC155 citations97
US6310078B1Oct 30, 2001
Substituted amino acids as erythropoietin mimetics
ORTHO MCNEIL PHARM INC179 citations97
US6924302B2Aug 2, 2005
Substituted triazole diamine derivatives as kinase inhibitors
ORTHO MCNEIL PHARM INC21 citations91
US6710048B2Mar 23, 2004
Pyrazine derivatives as modulators of tyrosine kinases
ORTHO MCNEIL PHARM INC25 citations91
US7317031B2Jan 8, 2008
Substituted triazole diamine derivatives as kinase inhibitors
ORTHO MCNEIL PHARM INC5 citations61
ORTHO PHARMA CORP
4 patentsUS5134155AJul 28, 1992
Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-coA reductase inhibitors
ORTHO PHARMA CORP25 citations93
US5315012AMay 24, 1994
Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds
ORTHO PHARMA CORP17 citations82
US5387693AFeb 7, 1995
Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole intermediate compounds
ORTHO PHARMA CORP17 citations74
US5250561AOct 5, 1993
Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors
ORTHO PHARMA CORP2 citations63
CONNOLLY PETER J
4 patentsUS8513423B2Aug 20, 2013
Piperidin-4-yl-azetidine diamides as monoacylglycerol lipase inhibitors
CONNOLLY PETER J8 citations83
US8183371B2May 22, 2012
Pyrazines as delta opioid receptor modulators
CONNOLLY PETER J2 citations62
US8637498B2Jan 28, 2014
Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors
CONNOLLY PETER J2 citations61
US8293750B2Oct 23, 2012
Pyrazines as delta opioid receptor modulators
CONNOLLY PETER J0 citations51
JANSSEN BIOTECH INC
3 patents(unassigned)
2 patentsCOATS STEVEN J
2 patentsOW STEVEN G
1 patentXU GUOZHANG
1 patentShowing the top 50 of 66 patents by PatentIndex Score.